APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucokinase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glucokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 July 2026186 pages

Choose your research edition.

Industry ResearchGlucokinase Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucokinase Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucokinase Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Glucokinase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucokinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucokinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucokinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucokinase market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucokinase Segment by Company

Amgen Inc

Eli Lilly and Co

Ligand Pharmaceuticals Inc

Merck & Co Inc

Poxel SA

Teijin Pharma Ltd

vTv Therapeutics Inc

Yuhan Corp

Glucokinase Segment by Type

LY-2608204

Sinogliatin

AM-9514

TMG-123

TTP-399

Others

Glucokinase Segment by Application

Metabolic Disorder

Obesity

Diabetes

Others

Glucokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucokinase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glucokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glucokinase Industry Trends Table 2. Glucokinase Industry Drivers Table 3. Glucokinase Industry Opportunities and Challenges Table 4. Glucokinase Industry Restraints Table 5. Global Glucokinase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glucokinase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glucokinase Sales by Manufacturers (kt) & (2021-2026) Table 8. Global Glucokinase Sales Market Share by Manufacturers Table 9. Global Glucokinase Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Glucokinase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glucokinase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glucokinase Manufacturers, Product Type & Application Table 13. Global Glucokinase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucokinase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of LY-2608204 Table 17. Major Manufacturers of Sinogliatin Table 18. Major Manufacturers of AM-9514 Table 19. Major Manufacturers of TMG-123 Table 20. Major Manufacturers of TTP-399 Table 21. Major Manufacturers of Others Table 22. Global Glucokinase Sales by Type 2021 VS 2025 VS 2032 (kt) Table 23. Global Glucokinase Sales by Type (2021-2026) & (kt) Table 24. Global Glucokinase Sales by Type (2027-2032) & (kt) Table 25. Global Glucokinase Sales Market Share by Type (2021-2026) Table 26. Global Glucokinase Sales Market Share by Type (2027-2032) Table 27. Global Glucokinase Revenue by Type 2021 VS 2025 VS 2032 (kt) Table 28. Global Glucokinase Revenue by Type (2021-2026) & (kt) Table 29. Global Glucokinase Revenue by Type (2027-2032) & (kt) Table 30. Global Glucokinase Revenue Market Share by Type (2021-2026) Table 31. Global Glucokinase Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Metabolic Disorder Table 33. Major Manufacturers of Obesity Table 34. Major Manufacturers of Diabetes Table 35. Major Manufacturers of Others Table 36. Global Glucokinase Sales by Application 2021 VS 2025 VS 2032 (kt) Table 37. Global Glucokinase Sales by Application (2021-2026) & (kt) Table 38. Global Glucokinase Sales by Application (2027-2032) & (kt) Table 39. Global Glucokinase Sales Market Share by Application (2021-2026) Table 40. Global Glucokinase Sales Market Share by Application (2027-2032) Table 41. Global Glucokinase Revenue by Application 2021 VS 2025 VS 2032 (kt) Table 42. Global Glucokinase Revenue by Application (2021-2026) & (kt) Table 43. Global Glucokinase Revenue by Application (2027-2032) & (kt) Table 44. Global Glucokinase Revenue Market Share by Application (2021-2026) Table 45. Global Glucokinase Revenue Market Share by Application (2027-2032) Table 46. Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 47. Global Glucokinase Sales by Region (2021-2026) & (kt) Table 48. Global Glucokinase Sales Market Share by Region (2021-2026) Table 49. Global Glucokinase Sales Forecasted by Region (2027-2032) & (kt) Table 50. Global Glucokinase Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 52. North America Glucokinase Sales by Country (2021-2026) & (kt) Table 53. North America Glucokinase Sales by Country (2027-2032) & (kt) Table 54. Europe Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 55. Europe Glucokinase Sales by Country (2021-2026) & (kt) Table 56. Europe Glucokinase Sales by Country (2027-2032) & (kt) Table 57. Asia Pacific Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 58. Asia Pacific Glucokinase Sales by Country (2021-2026) & (kt) Table 59. Asia Pacific Glucokinase Sales by Country (2027-2032) & (kt) Table 60. South America, Middle East and Africa Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 61. South America, Middle East and Africa Glucokinase Sales by Country (2021-2026) & (kt) Table 62. South America, Middle East and Africa Glucokinase Sales by Country (2027-2032) & (kt) Table 63. Global Glucokinase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Glucokinase Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Glucokinase Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Glucokinase Revenue Market Share by Region (2021-2026) Table 67. Global Glucokinase Revenue Market Share by Region (2027-2032) Table 68. Amgen Inc Company Information Table 69. Amgen Inc Business Overview Table 70. Amgen Inc Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Amgen Inc Glucokinase Product Portfolio Table 72. Amgen Inc Recent Development Table 73. Eli Lilly and Co Company Information Table 74. Eli Lilly and Co Business Overview Table 75. Eli Lilly and Co Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eli Lilly and Co Glucokinase Product Portfolio Table 77. Eli Lilly and Co Recent Development Table 78. Ligand Pharmaceuticals Inc Company Information Table 79. Ligand Pharmaceuticals Inc Business Overview Table 80. Ligand Pharmaceuticals Inc Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ligand Pharmaceuticals Inc Glucokinase Product Portfolio Table 82. Ligand Pharmaceuticals Inc Recent Development Table 83. Merck & Co Inc Company Information Table 84. Merck & Co Inc Business Overview Table 85. Merck & Co Inc Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck & Co Inc Glucokinase Product Portfolio Table 87. Merck & Co Inc Recent Development Table 88. Poxel SA Company Information Table 89. Poxel SA Business Overview Table 90. Poxel SA Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Poxel SA Glucokinase Product Portfolio Table 92. Poxel SA Recent Development Table 93. Teijin Pharma Ltd Company Information Table 94. Teijin Pharma Ltd Business Overview Table 95. Teijin Pharma Ltd Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teijin Pharma Ltd Glucokinase Product Portfolio Table 97. Teijin Pharma Ltd Recent Development Table 98. vTv Therapeutics Inc Company Information Table 99. vTv Therapeutics Inc Business Overview Table 100. vTv Therapeutics Inc Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. vTv Therapeutics Inc Glucokinase Product Portfolio Table 102. vTv Therapeutics Inc Recent Development Table 103. Yuhan Corp Company Information Table 104. Yuhan Corp Business Overview Table 105. Yuhan Corp Glucokinase Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Yuhan Corp Glucokinase Product Portfolio Table 107. Yuhan Corp Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Glucokinase Distributors List Table 111. Glucokinase Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Glucokinase Product Image Figure 2. Global Glucokinase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucokinase Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucokinase Sales (2021-2032) & (kt) Figure 5. Global Glucokinase Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Glucokinase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. LY-2608204 Image Figure 9. Sinogliatin Image Figure 10. AM-9514 Image Figure 11. TMG-123 Image Figure 12. TTP-399 Image Figure 13. Others Image Figure 14. Global Glucokinase Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 15. Global Glucokinase Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Glucokinase Sales Market Share by Type (2021-2032) Figure 17. Global Glucokinase Revenue by Type (2021 VS 2025 VS 2032) & (kt) Figure 18. Global Glucokinase Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Glucokinase Revenue Market Share by Type (2021-2032) Figure 20. Metabolic Disorder Image Figure 21. Obesity Image Figure 22. Diabetes Image Figure 23. Others Image Figure 24. Global Glucokinase Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 25. Global Glucokinase Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Glucokinase Sales Market Share by Application (2021-2032) Figure 27. Global Glucokinase Revenue by Application (2021 VS 2025 VS 2032) & (kt) Figure 28. Global Glucokinase Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Glucokinase Revenue Market Share by Application (2021-2032) Figure 30. North America Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 31. North America Glucokinase Sales Market Share by Country (2021-2032) Figure 32. U.S. Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 33. Canada Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 34. Mexico Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 35. Europe Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 36. Europe Glucokinase Sales Market Share by Country (2021-2032) Figure 37. Germany Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 38. France Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 39. U.K. Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 40. Italy Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 41. Netherlands Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 42. Asia Pacific Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 43. Asia Pacific Glucokinase Sales Market Share by Country (2021-2032) Figure 44. China Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 45. Japan Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 46. South Korea Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 47. Southeast Asia Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 48. India Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 49. Australia Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 50. South America, Middle East and Africa Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 51. South America, Middle East and Africa Glucokinase Sales Market Share by Country (2021-2032) Figure 52. Brazil Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 53. South Africa Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 54. Saudi Arabia Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 55. Turkey Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 56. Argentina Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 57. UAE Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 58. Egypt Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 59. Chile Glucokinase Sales and Growth Rate (2021-2032) & (kt) Figure 60. Global Glucokinase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Glucokinase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Glucokinase Revenue (2021-2032) & (US$ Million) Figure 63. North America Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Glucokinase Revenue (2021-2032) & (US$ Million) Figure 65. Europe Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Glucokinase Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Glucokinase Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Glucokinase Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Glucokinase Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • LY-2608204
  • Sinogliatin
  • AM-9514
  • TMG-123
  • TTP-399
  • Others
Applications
  • Metabolic Disorder
  • Obesity
  • Diabetes
  • Others
Companies covered
  • Amgen Inc
  • Eli Lilly and Co
  • Ligand Pharmaceuticals Inc
  • Merck & Co Inc
  • Poxel SA
  • Teijin Pharma Ltd
  • vTv Therapeutics Inc
  • Yuhan Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glucokinase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glucokinase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glucokinase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glucokinase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glucokinase Market Dynamics
  1. 2.1 Glucokinase Industry Trends
  2. 2.2 Glucokinase Industry Drivers
  3. 2.3 Glucokinase Industry Opportunities and Challenges
  4. 2.4 Glucokinase Industry Restraints
3 Glucokinase Market by Manufacturers
  1. 3.1 Global Glucokinase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glucokinase Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glucokinase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glucokinase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucokinase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glucokinase Manufacturers, Product Type & Application
  7. 3.7 Global Glucokinase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucokinase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucokinase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucokinase Tier 1, Tier 2, and Tier 3
4 Glucokinase Market by Type
  1. 4.1 Glucokinase Type Introduction
  2. 4.1.1 LY-2608204
  3. 4.1.2 Sinogliatin
  4. 4.1.3 AM-9514
  5. 4.1.4 TMG-123
  6. 4.1.5 TTP-399
  7. 4.1.6 Others
  8. 4.2 Global Glucokinase Sales by Type
  9. 4.2.1 Global Glucokinase Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Glucokinase Sales by Type (2021-2032)
  11. 4.2.3 Global Glucokinase Sales Market Share by Type (2021-2032)
  12. 4.3 Global Glucokinase Revenue by Type
  13. 4.3.1 Global Glucokinase Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Glucokinase Revenue by Type (2021-2032)
  15. 4.3.3 Global Glucokinase Revenue Market Share by Type (2021-2032)
5 Glucokinase Market by Application
  1. 5.1 Glucokinase Application Introduction
  2. 5.1.1 Metabolic Disorder
  3. 5.1.2 Obesity
  4. 5.1.3 Diabetes
  5. 5.1.4 Others
  6. 5.2 Global Glucokinase Sales by Application
  7. 5.2.1 Global Glucokinase Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Glucokinase Sales by Application (2021-2032)
  9. 5.2.3 Global Glucokinase Sales Market Share by Application (2021-2032)
  10. 5.3 Global Glucokinase Revenue by Application
  11. 5.3.1 Global Glucokinase Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Glucokinase Revenue by Application (2021-2032)
  13. 5.3.3 Global Glucokinase Revenue Market Share by Application (2021-2032)
6 Global Glucokinase Sales by Region
  1. 6.1 Global Glucokinase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucokinase Sales by Region (2021-2032)
  3. 6.2.1 Global Glucokinase Sales by Region (2021-2026)
  4. 6.2.2 Global Glucokinase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glucokinase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glucokinase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glucokinase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glucokinase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glucokinase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glucokinase Revenue by Region
  1. 7.1 Global Glucokinase Revenue by Region
  2. 7.1.1 Global Glucokinase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glucokinase Revenue by Region (2021-2026)
  4. 7.1.3 Global Glucokinase Revenue by Region (2027-2032)
  5. 7.1.4 Global Glucokinase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glucokinase Revenue (2021-2032)
  8. 7.2.2 North America Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glucokinase Revenue (2021-2032)
  11. 7.3.2 Europe Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glucokinase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glucokinase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glucokinase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Amgen Inc
  2. 8.1.1 Amgen Inc Company Information
  3. 8.1.2 Amgen Inc Business Overview
  4. 8.1.3 Amgen Inc Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amgen Inc Glucokinase Product Portfolio
  6. 8.1.5 Amgen Inc Recent Developments
  7. 8.2 Eli Lilly and Co
  8. 8.2.1 Eli Lilly and Co Company Information
  9. 8.2.2 Eli Lilly and Co Business Overview
  10. 8.2.3 Eli Lilly and Co Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Co Glucokinase Product Portfolio
  12. 8.2.5 Eli Lilly and Co Recent Developments
  13. 8.3 Ligand Pharmaceuticals Inc
  14. 8.3.1 Ligand Pharmaceuticals Inc Company Information
  15. 8.3.2 Ligand Pharmaceuticals Inc Business Overview
  16. 8.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
  18. 8.3.5 Ligand Pharmaceuticals Inc Recent Developments
  19. 8.4 Merck & Co Inc
  20. 8.4.1 Merck & Co Inc Company Information
  21. 8.4.2 Merck & Co Inc Business Overview
  22. 8.4.3 Merck & Co Inc Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Inc Glucokinase Product Portfolio
  24. 8.4.5 Merck & Co Inc Recent Developments
  25. 8.5 Poxel SA
  26. 8.5.1 Poxel SA Company Information
  27. 8.5.2 Poxel SA Business Overview
  28. 8.5.3 Poxel SA Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Poxel SA Glucokinase Product Portfolio
  30. 8.5.5 Poxel SA Recent Developments
  31. 8.6 Teijin Pharma Ltd
  32. 8.6.1 Teijin Pharma Ltd Company Information
  33. 8.6.2 Teijin Pharma Ltd Business Overview
  34. 8.6.3 Teijin Pharma Ltd Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
  36. 8.6.5 Teijin Pharma Ltd Recent Developments
  37. 8.7 vTv Therapeutics Inc
  38. 8.7.1 vTv Therapeutics Inc Company Information
  39. 8.7.2 vTv Therapeutics Inc Business Overview
  40. 8.7.3 vTv Therapeutics Inc Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 vTv Therapeutics Inc Glucokinase Product Portfolio
  42. 8.7.5 vTv Therapeutics Inc Recent Developments
  43. 8.8 Yuhan Corp
  44. 8.8.1 Yuhan Corp Company Information
  45. 8.8.2 Yuhan Corp Business Overview
  46. 8.8.3 Yuhan Corp Glucokinase Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yuhan Corp Glucokinase Product Portfolio
  48. 8.8.5 Yuhan Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucokinase Value Chain Analysis
  2. 9.1.1 Glucokinase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucokinase Production Mode & Process
  6. 9.2 Glucokinase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucokinase Distributors
  9. 9.2.3 Glucokinase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst